TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2016

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.

Edurne Arriola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.